Researchers

Selected publications

  • 2021

Publication 1
[Luisa Canto e Castro at al (2021). Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection . Eur J Immunol 10(10):1002]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1002/eji.202149619

Publication 2
[Miguel Esperança‐Martins at al (2021). Humoral Immune Response of SARS‐CoV‐2–Infected Patients with Cancer: Influencing Factors and Mechanisms. Oncologist. 9(9): e1619–e1632]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1002/onco.13828

Publication 3
[Filipe Cortes-Figueiredo at al (2021). From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel. Int J Mol Sci. 22(21): 12031]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.3390/ijms222112031

Publication 4
[Inês Leal at al (2021). A Non-Infectious Uveitis Multidisciplinary Clinic in a Tertiary Referral Center: Clinical Impact and Added Value. J Multidiscip Healthc. 2021; 14: 695–704]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.2147/JMDH.S292981

  • 2020

Publication 5
[Inês Gomes at al (2020). Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer. Oncotarget. 2020 May 12; 11(19): 1714–1728]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.18632/oncotarget.27576

Publication 6
[Patricia Figueiredo-Campos at al (2020). Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset. Eur J Immunol. 2020 Dec; 50(12): 2025–2040]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1002/eji.202048970

Publication 7
[Catarina Campos at al (2020). High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma. Genes (Basel) 2020 Apr; 11(4): 403]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.3390/genes11040403

  • 2019

Publication 8
[José M. Sánchez-Maldonado at al (2019). Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium. Sci Rep. 2019; 9: 14812.]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1038/s41598-019-51255-0

Publication 9
[Ana M Rodrigues at al (2019). Low Serum Levels of DKK2 Predict Incident Low‐Impact Fracture in Older Women. JBMR Plus. 2019 Jul; 3(7): e10179]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1002/jbm4.10179

  • 2018

Publication 10
[Céline S. Gonçalves et al (2018). WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma. Theranostics. 2018; 8(17): 4805–4823]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.7150/thno.25025

  • 2017

Publication 11
[Inês P. Perpétuo et al (2017). Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis. Biomed Res Int. 2017; 2017: 2690402]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1155/2017/2690402

Publication 12
[Gonçalo Barreto et al (2017). Toll-like receptors and their soluble forms differ in the knee and thumb basal osteoarthritic joints . Acta Orthop. 2017 Jun; 88(3): 326–333]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1080/17453674.2017.1281058

Publication 13
[Inês P. Perpétuo et al (2017). Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors. Front Med (Lausanne) 2017; 4: 5]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.3389/fmed.2017.00005

Publication 14
[Inês P. Perpétuo et al (2017). Methotrexate and low-dose prednisolone downregulate osteoclast function by decreasing receptor activator of nuclear factor-κβ expression in monocytes from patients with early rheumatoid arthritis. RMD Open. 2017; 3(1): e000365.]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1136/rmdopen-2016-000365

Publication 15
[Rita A. Moura et al (2017). B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis. PLoS One. 2017; 12(9): e0182927.]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1371/journal.pone.0182927

  • 2016

Publication 16
[Arlindo Ferreira et al (2016). The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases. Oncotarget. 2016 Jul 5; 7(27): 41380–41389.]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.18632/oncotarget.9356

Publication 17
[Inês Sousa et al (2016). Multicentric Genome-Wide Association Study for Primary Spontaneous Pneumothorax. PLoS One. 2016; 11(5): e0156103.]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1371/journal.pone.0156103

  • 2015

Publication 18
[Patrícia Abrantes et al (2015). Genetic Variants Underlying Risk of Intracranial Aneurysms: Insights from a GWAS in Portugal. PLoS One. 2015; 10(7): e0133422.]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1371/journal.pone.0133422

Publication 19
[Galber Rodrigues et al (2015). Improved serological detection of rheumatoid arthritis: a highly antigenic mimotope of carbonic anhydrase III selected in a murine model by phage display. Arthritis Res Ther. 2015; 17(1): 168.]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1186/s13075-015-0685-3

Publication 20
[Inês P. Perpétuo et al (2015). Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis. PLoS One. 2015; 10(12): e0144655.]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1371/journal.pone.0144655

Publication 21
[Dorothée et al (2015). TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits. PLoS One. 2015; 10(4): e0122271.]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1371/journal.pone.0122271

Publication 22
[Helena Canhão et al (2015). TRAF1/C5 but Not PTPRC Variants Are Potential Predictors of Rheumatoid Arthritis Response to Anti-Tumor Necrosis Factor Therapy. Biomed Res Int. 2015; 2015: 490295.]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1155/2015/490295

  • 2014

Publication 23
[Geraldine Cambridge et al (2014). Expression of the Inherently Autoreactive Idiotope 9G4 on Autoantibodies to Citrullinated Peptides and on Rheumatoid Factors in Patients with Early and Established Rheumatoid Arthritis. PLoS One. 2014; 9(9): e107513.]
Type of article (original article/review/opinion article/editorial/letters): original article
DOI: 10.1371/journal.pone.0107513

Last updated: October 25, 2022